dr. claude lambert challenges, solutions and innovations in modern flowcytometr

54
ysis of Cell populati By Flow cytometry Claude LAMBERT Labo Immunologie CHU Saint-Etienne European Society of Clinical Cell analysis

Upload: hitham-esam

Post on 08-Apr-2017

31 views

Category:

Health & Medicine


1 download

TRANSCRIPT

Page 1: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

Analysis of Cell populationsBy Flow cytometry

Claude LAMBERTLabo Immunologie CHU Saint-Etienne

European Society of Clinical Cell analysis

Page 2: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr
Page 3: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

Fluorochrome detection

1 parameter

FluorochromeBest conjugateCompensationsNeg controls fmoartifacts

Page 4: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

525 575 620 675 695 767

FITC

530/30

SignalSignal

Not all fluorescence is captured by your PMT

Page 5: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

One fluorochrome one spectrum

spectraviewer

Page 6: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

Instrument

1 - Know your optical bench

NAVIOS Laser 405 nm, 40mW Laser 488nm, 22 mW Laser 638 nm, 25mWFL9 FL10 FITC PE PE-TEXAS RED PE-Cy5 PE-Cy7 APC ALEXA FL 500 APC-Cy7

V450 V550 B525 B575 B620 B675 B780 R660 R755 R785Filtres 450/40 550/40 525/40 575/30 620/30 695/30 755 LP 660/20 725/20 755 LP

Optical band 430 à 470 530 à 570 505 à 545 560 à 590 605 à 635 680 à 710 >755 650 à 670 715 à 735 755Mirors 480 SP 550 SP 595 SP 655 SP 730 SP 710 SP 750 SPBand finale 430 - 480 530-570 505 à 545 560-590 605-635 680-710 >755 650-710 715 à 735 755

Canto II Laser 405 nm, 40mW Laser 488nm, 13 mW Laser 633 nm, 11mWHoriz V450

Horiz V500 FITC PE PerCP PE-Cy7 FL5 FL6

V450 V510 B530 B585 B670 B785 R660 R780filtres 450/50 510/50 fi

530/30 585/42 670 LP 780/60 660/20 780/60

Band finale 425 - 475 502-535 Ba

515-545 564-606 670 - 735 750-810 650-670 750-810

Page 7: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

Canto

Navios

Page 8: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

Canto

Navios

Page 9: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

Leaking

2 - Know your fluorochromes

Page 10: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

Compensations

Page 11: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

525 575 620 675 695 767

530+30585+42

670 LP780+60

FITC

PE

PE-TxR

PE-Cy5

PerCP

PerCP-Cy5.5

PE-Cy7

530/30

= 530/30 -

Page 12: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr
Page 13: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

525 575 620 675 695 767

530+30585+42

670 LP780+60

FITC

PE

PE-TxR

PE-Cy5

PerCP

PerCP-Cy5.5

PE-Cy7

Page 14: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr
Page 15: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

Undercompensated

Page 16: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

Compensations

Correct compensations

3 – Mind the compensations

Page 17: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

Compensations

One representative conjugateStrong labellingStable fluorescencePossible surrogates

4 – Optimize your compensation settings

Page 18: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

Inter laser Compensations

Page 19: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

Inter laser Compensationsexception

Blue laser

Red laser

5 – Mind inter laser excitation

Page 20: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

Optimum labelling

Page 21: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

Fluorescence Intensité

Always be saturated

Highest signal/noise ratioSignal correlated to antigen density

Page 22: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr
Page 23: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

SATURATION

6 - Consider the number of cells you analyze

Cell number

Page 24: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

0.25 0.5 1 2 4 8 16 32 64 µl of Antibody

Fluorescence intensity

Saturation

Too much saturation Rise non specific labelling

Optimum labelling intensity

Page 25: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

0.25 0.5 1 2 4 8 16 32 64 µl of Antibody

Fluorescence intensity

Find the best (minimal) saturationTITRATION

7 – ALWAYS at SATURATION

Page 26: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

0.25 0.5 1 2 4 8 16 32 64 µl of Antibody

Fluorescence intensity

WASH

8 – Wishing reduce noise

Page 27: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

Optimize your conjugate

Page 28: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

JW Gratama Cytometry 1998

Antigen densityAssign copy numbers of PE molecules bound per bead

Antiboy Bound per Cell

Page 29: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

Bikoue A et al, Cytometry 1996; 26: 137-147

Rule 4 : marker densities are not equivalents

9 – Mind marker density on cells

Page 30: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

Best conjugate

Fluorochroms are not equivalent

Page 31: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

Best conjugate

10 - Stronger Fluorochroms dimer staining (lower density)

Page 32: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

Visualization of Spectral Overlap

Gallios/Navios Flow Cytometers

2 types of distortion:

‚Silent‘ Fluorochromes:• bright markers (gating)

‚Untouchable‘ Channels• dimly expressed antigens

depends on instrument configuration, and fluorochromes.

11 – dim expression : stronger and untouchable fluorochome

Page 33: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

Optimize your Dot plots

Page 34: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

Dot plots are more informative than histograms

3 populations

In fact more than 3 populations

2 dim graphs are most precise Graphs

Page 35: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

Other types of graphs

Level curvesbetter definiton of valley

12 – Take advantages of plot types

Page 36: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

Sequential selection of population

Quantification of sub groups

gives % of cells

Yes …. But % of what??

Page 37: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

Rule 6 : Always make your gating strategy very clear

Page 38: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

28.3%

Gating Hierarchy

Page 39: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

Graphs ConditionningMention

Parent population (s)

28.3%

Proper labelling info

Page 40: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

IL-17

IL-2

2

% of what??

Page 41: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

Kamnesh R. Pradhan, et col Cytometry Part B 2011; 80B: 335–338

Gating strategy explained in a paper

13 – Clearly design & describe gating strategy

Page 42: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

Positivity

Page 43: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

What is positive?

Decision threshold difficult

Reproducibility among different samples even more difficult

Repeattibility between labs, operators..

14 – Be sure of positive threshold

Page 44: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

NEGATIVITY

Cells alones(auto-fluorescence)

But does not exclude non specific labelling??

Page 45: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

non specific deposit on cells

PC5

For each label

Page 46: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

Exclude non specific labelling

Isotype Controls =Same providerSame isotype

Same fluorochrome

Use non specific Surrogate antibodiesThe closest to the protocol

ECD

FITC

PE/RD1PC5

Page 47: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

Use cells in the sample that you know they are negative for the

antibody considered

ECD

FITC

PE/RD1PC5

PC5

Internal negative cell

Page 48: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

Internal negative control

Use negative cells (red) as negative control..

Page 49: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

Validate negativity Inside the multiple labelling

FULL FLUORESCENCE MINUS ONE (FMO)Test one color negativity while all other labelings are there

All except CD19 All except CD8

15 – Be sure on the negative

Page 50: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

Follow acquisition

Exclude bublesTemps

Page 51: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

Surveiller acquisition

TAB

16 – Keep clean acquisition

Page 52: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

Good Flowcytometry analysis Knowing your Optical scheme

Good Negative controls (including FMO)

Proper settings and do not change it

Positive threshold to be validated on each sample

Label saturation…. But not too much titration

Avoid non specific labelling

Gating strategy and graph information

Optimize your conjugates

Page 53: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr
Page 54: Dr. claude lambert   challenges, solutions and innovations in modern flowcytometr

Design

Modern art